EUVIMEDEUVIMED entdecken
Leitlinie

WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults

Mohammad Kazem Fallahzadeh, Krista Lentine, Neeraj Singh

JAMA · 28.04.2026 · 335 (16) · 1450

DOI: 10.1001/jama.2026.0678 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA, erschienen am 28.04.2026. Verfasst von Mohammad Kazem Fallahzadeh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Section of Nephrology, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri.
  • Division of Nephrology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

Zitieren

APA

Fallahzadeh, M. K., Lentine, K., & Singh, N. (2026). WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults. JAMA, 335(16), 1450. https://doi.org/10.1001/jama.2026.0678

Vancouver

Fallahzadeh MK, Lentine K, Singh N. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults. JAMA. 2026;335(16):1450. doi:10.1001/jama.2026.0678

BibTeX
@article{Fallahzadeh2026,
  author = {Fallahzadeh, Mohammad Kazem and Lentine, Krista and Singh, Neeraj},
  title = {WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {16},
  pages = {1450},
  doi = {10.1001/jama.2026.0678}
}
Kostenlos starten →